.avif&w=256&q=75){kind=logo}
Cancer screening is a topic full of confusion. Blood tests called tumor markers get talked about a lot. But they have specific, limited jobs. Using them to screen healthy adults often causes false alarms. It can lead to worry and extra tests you did not need. This guide explains what each cancer blood test can tell you, and what it cannot.
Cancer Screening Blood Tests: What's Available and What They Detect
Written by &you Labs Team
Updated September 14, 2026
Quick answer
Most tumor markers are built to track a cancer you already have. They are not built to screen healthy adults. A few exceptions exist. PSA can screen for prostate cancer in men over 50 with risk factors. AFP can screen for liver cancer in people with long-term hepatitis B or C. Newer multi-cancer blood tests show promise but are still being studied. Most cancer screening still relies on imaging and tissue tests, not blood.
How tumor markers work
Tumor markers are usually proteins. Cancer cells make some of them. Your body makes others in response to cancer. Doctors measure these in your blood.
Here are the key limits to know:
- Most tumor markers only rise once cancer has grown large.
- Many rise for reasons that have nothing to do with cancer, like infection, swelling, or pregnancy.
- These tests miss many real cancers, and they flag many false alarms too.
- Their value for screening healthy people is often quite limited.
Tumor markers work best for three jobs:
- Tracking a cancer you already have, to see if treatment works.
- Screening people in a clearly defined high-risk group.
- Helping sort out symptoms that need more investigation.
The common tumor markers
PSA (prostate-specific antigen)
PSA is a protein made by the prostate. Normal is under 4 ng/mL, though this shifts with age.
Doctors use PSA to screen for prostate cancer in men over 50. They also use it earlier for men with risk factors. A high PSA does not always mean cancer. It can also come from an enlarged prostate, an infection, or recent sex. New guidelines favor a real conversation with your doctor about the pros and cons before you test.
Best use: men 50 to 70, with a shared decision alongside your doctor. Earlier, from age 40 to 45, if you have a family history. Also useful when you have urinary symptoms that need a closer look.
CA-125
CA-125 is a protein that rises in some ovarian cancers. Normal is under 35 U/mL.
This test often rises for reasons that have nothing to do with cancer. Endometriosis, fibroids, pelvic swelling, and even pregnancy can raise it. It misses many early ovarian cancers too. Doctors do not recommend it for routine screening in women at average risk.
Best use: tracking known ovarian cancer. Checking a pelvic mass found on imaging. Screening women with a known BRCA gene change, under a specialist's care.
CEA (carcinoembryonic antigen)
CEA rises in some colon, lung, and other cancers. Smoking, gut inflammation, and benign tumors can raise it too. It is not built for screening.
Best use: tracking known colon cancer after treatment. Helping sort out a suspicious finding.
AFP (alpha-fetoprotein)
AFP rises in liver cancer and in some rare tumors called germ cell tumors. Normal in adults is under 10 ng/mL.
Best use: watching for liver cancer in people with long-term hepatitis B or C, usually every 6 months alongside an ultrasound. Also used to track known liver tumors or germ cell tumors.
CA 19-9
CA 19-9 rises in some pancreatic and bile duct cancers. It also rises from pancreatitis and blocked bile ducts, which have nothing to do with cancer. It is not built for screening.
Best use: tracking known pancreatic cancer. Helping sort out a suspicious finding on imaging.
CA 15-3 and CA 27-29
These proteins rise in some breast cancers. Doctors use them to track known breast cancer, not to screen for it. Mammograms remain the screening tool for breast cancer.
Beta-hCG
Beta-hCG is a pregnancy hormone. It also rises in some rare tumors. Doctors use it for pregnancy tests and for tracking rare germ cell tumors.
Calcitonin
Calcitonin rises in a rare cancer called medullary thyroid cancer. Doctors use it to screen family members with a rare inherited syndrome called MEN2. It is not a routine thyroid test.
Newer multi-cancer blood tests
A newer type of test looks for tiny bits of cancer DNA floating in your blood. These are called multi-cancer early detection tests.
What they do well
- They can flag several cancer types from one blood draw.
- They show real promise for cancers without a good screening test today, like pancreatic, ovarian, and esophageal cancer.
- When they come back positive, that result usually means something real.
What they cannot do yet
- Replace mammograms, colonoscopies, or Pap smears. Those tests still catch early cancer better.
- Catch most stage 1 cancers. Their strength lies more with later stages.
- Give you a final answer on their own. A positive result always needs more testing.
- Major medical groups do not yet recommend them for routine, general screening.
These tests are a promising new frontier. They are not yet a standard part of care.
Which cancers have a good blood-screening option?
Honestly, not many. The strongest evidence supports:
- PSA for prostate cancer, with real limits to understand first.
- AFP plus ultrasound for liver cancer, in people with long-term hepatitis B or C.
- A few markers for tracking known testicular cancer.
For most other cancers, these tools work better:
Cancer type | Best screening tool |
|---|---|
Breast | Mammogram |
Cervical | Pap smear or HPV test |
Colorectal | Colonoscopy or a stool-based test |
Lung, in heavy smokers | Low-dose CT scan |
Skin | A skin check by a doctor |
A general screening schedule
Group | What to consider |
|---|---|
Women 21 and up | Pap smear every 3 years, or HPV testing every 5 years starting at 30 |
Women 40 and up | Yearly mammogram, or as your doctor advises |
Adults 50 and up | Colon cancer screening, by colonoscopy or a stool test |
Men 50 and up, earlier with risk factors | A conversation with your doctor about PSA screening |
Long-term hepatitis B or C carriers | AFP plus ultrasound every 6 months |
Heavy current or former smokers, ages 55 to 80 | A yearly low-dose CT scan, where available |
High-risk families, like BRCA or Lynch syndrome | A specialized plan with genetic counseling |
Want to see where a &you Labs cancer test fits into your own screening plan? Book your &you Labs panel and talk it through with a doctor.
Why full tumor marker panels usually backfire
Many clinics sell a "tumor marker panel" as part of an executive checkup. Here is why doctors often advise against this:
- Running many markers at once raises your odds of a false alarm.
- Most early cancers do not raise these markers at all.
- A false alarm often leads to scans and biopsies, which carry their own risks.
- The worry from an unclear result is real and can be hard to shake.
- Large studies show no drop in cancer deaths from this kind of screening.
When tumor markers do make sense
- Watching a defined high-risk group, like AFP for hepatitis carriers.
- Sorting out a symptom or an imaging finding that needs an answer.
- Tracking a cancer you have already been diagnosed with.
- A specific research or specialist setting, tied to a clear clinical question.
How &you Labs approaches cancer-related testing
A &you Labs panel includes hepatitis B screening, since it matters for Filipino health. It includes PSA for men 40 and up, framed as a conversation to have with your doctor. It does not include a routine tumor marker panel by default. For breast, cervical, colon, and lung cancer, the right next step is imaging or a specialist visit, not a blood test.
Frequently asked questions
Should I add CA-125 or CEA to my yearly checkup?
Usually not, unless you have a specific risk factor or symptom. For most healthy adults, these tests cause more false alarms than they solve.
What is the single most useful cancer blood test for me?
It depends on your age, sex, and risk factors. For Filipino adults, hepatitis B screening ranks high. PSA matters for men after 50. Beyond that, screening tests like colonoscopy and mammograms do more work than blood tests.
Are the newer multi-cancer blood tests worth trying?
They are promising, but still being studied. Major medical groups do not yet recommend them for routine use. If you are curious, talk to your doctor about what they can and cannot tell you.
If my tumor markers come back normal, does that rule out cancer?
No. Most early cancers do not raise tumor markers at all. A normal result does not rule cancer out.
What about genetic testing for cancer, like BRCA?
This is a specialized test for people with a strong family history or an early-onset cancer in the family. It always comes with genetic counseling. It is not a routine screening test.
Key takeaways
- Most tumor markers are built to track a known cancer, not to screen healthy people.
- PSA and AFP, used the right way, have a real screening or monitoring role.
- Imaging tests like mammograms, colonoscopies, and low-dose CT scans do the heavy lifting in cancer screening.
- Full tumor marker panels in checkup packages often cause more false alarms than useful answers.
- Newer multi-cancer blood tests are promising but are not yet standard care.
